Launched in 2007, this conference is the leading international meeting covering all aspects of cilia and cilia-related diseases, providing the premier forum to share the newest research. The program will cover the field from basic research in model organisms to the development of treatments for human ciliopathies.
PEGS Boston Summit is the Essential Industry Conference for Streamlining Biologics Development The PEGS Boston Summit brings together leading experts at the forefront of biologics innovation, providing insights into the latest technologies, research, and advancements in drug development, protein and antibody engineering, immunotherapy, immunogenicity, expression platforms, multispecific antibodies, machine learning and AI in biologics, and...
Tracks and Themes Track 1: Advances in Discovery, Formulation, and Delivery of New Modalities A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and...
Location: Jericho National Golf Club, New Hope, PA Over a hundred biotech leaders and other golfers will join us at this top-tier golf course on May 13 for a day of great food, refreshments and fun. Interested in joining us? Contact Alaina Schukraft at Alaina.Schukraft@hepb.org! For more information click here.
The BIOTECHGATE DIGITAL PARTNERING event series was started in spring 2020 due to the COVID-19 pandemic. We offer companies the possibility to conduct their business development and interact with partners, clients, licensees / licensors and suppliers in a secure, online environment. This offer is for anybody working in business development and licensing in life sciences...
The Fierce Pharma PR & Communications Summit West is the one and only conference on the west coast dedicated to providing life science communicators with timely industry updates and best practices for successful communications strategies during today's complex healthcare environment. We're bringing this dynamic community together in-person to connect and create meaningful and in-depth discussions on not only...
We are very excited to announce our outdoor Biotech Community Event at the Biovista Life Science Campus. We are inviting all the tenants and all local life science researchers and entrepreneurs in the surrounding area to attend. This is a special Biotech Community Event sponsored by some of the top scientific suppliers in the industry,...
Immune therapies and obesity treatments are getting lots of attention, and many pundits would tell you platform strategies and gene therapies have fallen out of favor. And while the Biotech Index has rebounded almost 50% from its October 2023 low, many companies are still struggling to fundraise. Our outstanding group of panelists will help distill...
2024 is a pivotal year for US healthcare, in particular for the pharma and biotech industries. A presidential election will influence crucial policies on drug pricing and health financing for years to come. AI technologies are evolving from buzzwords to making an impact in drug R&D. Pharma is facing a huge patent cliff. And the...
Medicine’s future, now To a person 20 years ago, today’s medicine would seem like science fiction: routine DNA sequencing, gene editing, and surgery that can help an 80-year-old Mick Jagger dance. So what will the next two decades bring? We’ll peer into the mists, looking at GLP-1 drugs for psychiatry, a new age of individualized...
Don't miss your chance to hear from leading Life Science and CRE experts about the state of the industry and development in Philadelphia. Agenda: 8:30-9:15am: Breakfast & Networking 9:15-10am: Panel 1 with Reporter Paul Schwedelson 10-11am: Panel 2 with Senior Reporter John George Panel 1: After developers rushed to build new lab space, tenant demand and...
Join us for company presentations, one-on-one investor meetings, and meetings with H.C. Wainwright investment banking & research teams. Who Should Participate? Public & private companies Industry executives Business development executives Institutional investors Private equity firms Venture capitalists
